Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1599-1600

  Wortmann, Glenn W ^a   Bennett, Steven P ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; CASE REPORT; FATALITY; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETHARGY; MALE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; FATAL OUTCOME; HUMANS; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OFLOXACIN; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033371312     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313557     Document Type: Article

References (4)

1. 1. Bartlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811-38.
2. 2. Doern GV, Pfaller MA, Erwin ME, Brueggemann AB, Jones RN. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada - 1997 results from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 1998; 32:313-6.
3. 3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: 9th informational supplement. NCCLS document M100-S9. Villanova, PA: National Committee for Clinical Laboratory Standards, 1999.
4. 4. Ho PL, Que TL, Tsang DN, NG TK, Chow KH, Seto WH. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1999; 43: 1310-3.